4//SEC Filing
TETRALOGIC PHARMACEUTICALS CORP 4
Accession 0001171843-15-000469
CIK 0001361248operating
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 2:37 PM ET
Size
8.0 KB
Accession
0001171843-15-000469
Insider Transaction Report
Form 4
Meyers Peter A.
CFO & Treasurer
Transactions
- Award
Restricted Stock Unit
2015-01-28+75,000→ 0 totalExp: 2018-01-28→ Common Stock (75,000 underlying) - Award
Stock Option
2015-01-28$5.25/sh+100,000$525,000→ 611,195 totalExercise: $5.25Exp: 2025-01-28→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Beginning January 28, 2015, stock options will vest and become exercisable at 2% per month until fully vested. Stock options are subject to the reporting person's continued service as of each vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of TetraLogic Pharmaceuticals Corporation common stock. All 75,000 restricted stock units shall vest on January 28, 2018. Restricted stock units are subject to the reporting person's continued service as of the vesting date.
Documents
Issuer
TETRALOGIC PHARMACEUTICALS CORP
CIK 0001361248
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001361248
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 2:37 PM ET
- Size
- 8.0 KB